company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5291168.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5291168.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,888.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2856525.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,306982.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2126773.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2126773.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7234.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7234.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7234.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-757340.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1500000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-282752.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,459908.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,459908.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1674099.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q3,2010-07-01,2010-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-82585.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5968204.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5968204.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3155.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,558825.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1425788.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3980436.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3980436.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4766.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4766.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4766.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3793373.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1112000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1500065.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,50801000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,282752.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47678444.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47678444.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,43693242.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,109773.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8604717.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8604717.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8090.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1398101.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,260356.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6938170.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6938170.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-80207.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-80207.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-80207.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,47585448.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,145452.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47730900.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47730900.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,40712523.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,262888.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10120499.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10120499.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11842.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,68560.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,961572.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1599803.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7478722.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7478722.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-103236.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46940191.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1282500.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-104892.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-45865819.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45760927.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1641299.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,147596.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1788895.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1788895.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-51450754.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,265784.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13910326.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13910326.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23658.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,293440.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2485964.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2023072.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9084192.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9082192.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-374139.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15871809.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15626500.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-108.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-619556.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-619448.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-52200.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-32747.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,89952.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5005.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5005.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-25000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9721635.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,175772.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11665000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11665000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-33000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,295000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3559000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-950000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8794000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8794000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-136000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14900000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14764000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14764000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-10875000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-73000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10000000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,486000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-462000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-462000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5516000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 14:38:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,341000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21799000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21799000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,70000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,303000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3841000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4900000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12685000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12711000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-476000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8998000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15101000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5627000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5627000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-75000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,73000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,84000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-2000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,102000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,182000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,182000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,27000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6875000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,177000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18142000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18142000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,99000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,329000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3606000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7371000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21479000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21479000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-192000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34267000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4958000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29501000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29501000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-339000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,78008000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2900000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,80569000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,80569000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-27000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29562000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:12:53+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,177000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18897000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18897000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,111000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,507000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6744000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-616000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12151000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12104000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-262000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24119000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12958000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11423000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11423000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-894000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,28000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2220000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1354000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1354000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-27000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22200000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,169000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12467000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12467000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8279000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4188000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4188000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6915000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-895000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-16000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2858000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1947000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1947000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,37000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4711000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,163000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-184000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-427000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-611000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,105000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11104000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11209000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-894000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2060000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1166000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1166000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11767000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,129000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,115000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15776000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15776000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,298000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,367000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8776000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3002000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9337000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9337000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-578000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5834000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17102000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10690000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10690000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-894000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1757000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,863000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,863000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-26000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2190000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,121000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:12:53+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,181000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9622000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9622000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,232000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,287000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8984000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10540000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10659000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10659000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-770000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32567000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27785000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5552000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5552000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-895000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,582000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-313000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-313000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-27000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16551000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,112000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,563000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5871000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5871000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,276000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2639000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7181000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4515000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8740000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8740000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1732000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8093000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13385000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3560000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3560000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8927000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-35000000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,325000000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,60548000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-85679000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,255942000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,255942000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,261000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,268503000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,94000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,219000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8116000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8116000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,413000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-2228000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13549000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5587000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9205000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9205000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-860000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,52340000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,51480000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,51480000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1312000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-1000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,495000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-818000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-818000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,917000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,60784000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,75000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,126000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15825000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15825000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,398000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5235000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12720000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7765000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5237000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5237000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-316000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-325000000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-325316000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-325316000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4011000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,24962000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1551000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22502000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22502000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-504000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-308555000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3379000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 16:13:08+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,417000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11150000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11150000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,316000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4952000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12841000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8051000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,15010000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,15010000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-303000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-303000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-303000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,1000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,343000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,344000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,344000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,129000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15180000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,192000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,286000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9765000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9765000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,464000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5094000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9467000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9064000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14324000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14324000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-588000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-588000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-588000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-24640000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-24640000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-24640000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,80000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10824000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3444000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,315000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36599000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36599000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,637000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4902000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10992000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11952000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8116000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8116000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-672000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-672000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-672000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1041000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1041000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1041000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,510000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7237000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,189000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,301000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65554000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65554000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,490000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5046000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,40571000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2079000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21526000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21526000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-524000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-524000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-524000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-6000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,273000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21783000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3440000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,2016-01-01,2016-03-31,2016-05-16 16:13:08+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,458000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46809000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46809000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,501000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5046000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,32259000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10316000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1313000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1313000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-39000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-39000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2828000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-683000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2145000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2145000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-73000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3346000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,191000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,579000.0
